Emphysema and Myelodysplastic syndrome - from FDA reports

Summary

Myelodysplastic syndrome is reported only by a few people with Emphysema. We study 2 people who have Myelodysplastic syndrome and Emphysema from FDA . Find out below who they are, other conditions they have and drugs they take.

What to expect?

If you have Emphysema and Myelodysplastic syndrome, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who have Emphysema and Myelodysplastic syndrome

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Oct, 23, 2017

2 people who have Emphysema and Myelodysplastic Syndrome are studied.


Number of reports submitted per year:

Would you have Myelodysplastic syndrome when you have Emphysema?

Gender of people who have Emphysema and experience Myelodysplastic Syndrome *:

  • female: 50 %
  • male: 50 %

Age of people who have Emphysema and experience Myelodysplastic Syndrome *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Top co-existing conditions for these people *:

  • Chronic Obstructive Pulmonary Disease (2 people, 100.00%)
  • Paroxysmal Nocturnal Haemoglobinuria (1 person, 50.00%)

Most common drugs for these people *:

  • Tudorza Pressair (1 person, 50.00%)
  • Symbicort (1 person, 50.00%)
  • Soliris (1 person, 50.00%)

Top symptoms for these people *:

  • Neutrophil Count Decreased (1 person, 50.00%)
  • Haemoglobin Decreased (1 person, 50.00%)
  • Depression (1 person, 50.00%)
  • Anaemia (1 person, 50.00%)
  • Abdominal Pain (1 person, 50.00%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Myelodysplastic syndrome and Emphysema?

Expand the study to include reports from both FDA and eHealthMe

Myelodysplastic syndrome and Emphysema from FDA and eHealthMe reports

Emphysema

Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs) can be treated by Spiriva, Advair diskus 250/50, Symbicort, Albuterol sulfate, Albuterol (latest reports from 19,182 Emphysema patients)

Myelodysplastic Syndrome

Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged) has been reported by people with myelodysplastic syndrome, multiple myeloma, idiopathic thrombocytopenic purpura, high blood pressure, rheumatoid arthritis (latest reports from 32,921 Myelodysplastic syndrome patients).

Browse all symptoms of Emphysema

a b c d e f g h i j k l m n o p q r s t u v w x y z

Could your drugs cause Myelodysplastic syndrome

Myelodysplastic syndrome

Other conditions that could case Myelodysplastic syndrome

Myelodysplastic syndrome

Related studies

What would happen?

Forecast new side effects and undetected conditions when you have Emphysema and Myelodysplastic syndrome.

Can you answer these questions?

More questions >

You may be interested in these reviews

More reviews >